• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Sublingual Ketamine: An Option for Increasing Accessibility of Ketamine Treatments for Depression?

作者信息

Swainson Jennifer, Khullar Atul

机构信息

Department of Psychiatry, University of Alberta, Edmonton, Alberta, Canada.

Department of Psychiatry, Misericordia Community Hospital, Edmonton, Alberta, Canada.

出版信息

J Clin Psychiatry. 2020 Jan 28;81(1):19lr13146. doi: 10.4088/JCP.19lr13146.

DOI:10.4088/JCP.19lr13146
PMID:31995676
Abstract
摘要

相似文献

1
Sublingual Ketamine: An Option for Increasing Accessibility of Ketamine Treatments for Depression?舌下含服氯胺酮：增加抑郁症氯胺酮治疗可及性的一种选择？
J Clin Psychiatry. 2020 Jan 28;81(1):19lr13146. doi: 10.4088/JCP.19lr13146.
2
Promises and concerns regarding the use of ketamine and esketamine in the treatment of depression.关于氯胺酮和艾司氯胺酮用于治疗抑郁症的前景与担忧。
Acta Psychiatr Scand. 2019 Aug;140(2):182-183. doi: 10.1111/acps.13063.
3
Can we confidently use ketamine as a clinical treatment for depression?我们能否放心地将氯胺酮用作抑郁症的临床治疗手段？
Lancet Psychiatry. 2018 Jan;5(1):11-12. doi: 10.1016/S2215-0366(17)30480-7.
4
Synaptic potentiation and rapid antidepressant response to ketamine in treatment-resistant major depression: A replication study.难治性重度抑郁症患者突触增强和氯胺酮快速抗抑郁反应：一项复制研究。
Psychiatry Res Neuroimaging. 2019 Jan 30;283:64-66. doi: 10.1016/j.pscychresns.2018.09.001. Epub 2018 Sep 12.
5
Frontiers in Therapy of Treatment-Resistant-Depression: A Future Role of Ketamine?难治性抑郁症的治疗前沿：氯胺酮的未来作用？
J Okla State Med Assoc. 2015 Mar;108(3):88-9.
6
Time until relapse after augmentation with single-dose ketamine in treatment-resistant depression.难治性抑郁症单次剂量氯胺酮增强治疗后至复发的时间。
Psychiatry Clin Neurosci. 2018 Aug;72(8):623. doi: 10.1111/pcn.12675. Epub 2018 Jun 19.
7
[Ketamine--a new treatment option for therapy-resistant depression].[氯胺酮——难治性抑郁症的一种新治疗选择]
Fortschr Neurol Psychiatr. 2015 Feb;83(2):91-7. doi: 10.1055/s-0034-1398967. Epub 2015 Feb 27.
8
Oral ketamine augmentation for chronic suicidality in treatment-resistant depression.口服氯胺酮增效治疗难治性抑郁症中的慢性自杀倾向。
Aust N Z J Psychiatry. 2014 Jul;48(7):686. doi: 10.1177/0004867414520754. Epub 2014 Jan 22.
9
Impact of oral ketamine augmentation on hospital admissions in treatment-resistant depression and PTSD: a retrospective study.口服氯胺酮增效治疗对难治性抑郁症和 PTSD 患者住院的影响：一项回顾性研究。
Psychopharmacology (Berl). 2018 Feb;235(2):393-398. doi: 10.1007/s00213-017-4786-3. Epub 2017 Nov 18.
10
Side-effects associated with ketamine use in depression: a systematic review.氯胺酮用于治疗抑郁症的副作用：一项系统评价
Lancet Psychiatry. 2018 Jan;5(1):65-78. doi: 10.1016/S2215-0366(17)30272-9. Epub 2017 Jul 27.

引用本文的文献

1
Change in Negative Affective Bias following a Single Ketamine Treatment for Treatment-Resistant Depression.单次氯胺酮治疗难治性抑郁症后负性情感偏向的变化
Depress Anxiety. 2023 Aug 19;2023:3371272. doi: 10.1155/2023/3371272. eCollection 2023.
2
At-home, telehealth-supported ketamine treatment for depression: Findings from longitudinal, machine learning and symptom network analysis of real-world data.家庭环境下、远程医疗支持的氯胺酮治疗抑郁症：真实世界数据的纵向、机器学习和症状网络分析结果。
J Affect Disord. 2024 Sep 15;361:198-208. doi: 10.1016/j.jad.2024.05.131. Epub 2024 May 27.
3
The molecular pathophysiology of depression and the new therapeutics.
抑郁症的分子病理生理学与新疗法
MedComm (2020). 2022 Jul 21;3(3):e156. doi: 10.1002/mco2.156. eCollection 2022 Sep.
4
Non-parenteral Ketamine for Depression: A Practical Discussion on Addiction Potential and Recommendations for Judicious Prescribing.非肠道用氯胺酮治疗抑郁症：关于成瘾潜力的实用讨论及合理处方建议。
CNS Drugs. 2022 Mar;36(3):239-251. doi: 10.1007/s40263-022-00897-2. Epub 2022 Feb 14.
5
Effect of intravenous low-dose S-ketamine on pain in patients with Complex Regional Pain Syndrome: A retrospective cohort study.静脉注射低剂量 S-氯胺酮对复杂性区域疼痛综合征患者疼痛的影响：一项回顾性队列研究。
Pain Pract. 2021 Nov;21(8):890-897. doi: 10.1111/papr.13056. Epub 2021 Jul 24.
6
An Update on the Efficacy and Tolerability of Oral Ketamine for Major Depression: A Systematic Review and Meta-Analysis.口服氯胺酮治疗重性抑郁症的疗效和耐受性更新：系统评价和荟萃分析。
Psychopharmacol Bull. 2020 Sep 14;50(4):137-163.
7
Ketamine as an antidepressant: overview of its mechanisms of action and potential predictive biomarkers.氯胺酮作为一种抗抑郁药：其作用机制及潜在预测生物标志物概述。
Ther Adv Psychopharmacol. 2020 May 11;10:2045125320916657. doi: 10.1177/2045125320916657. eCollection 2020.